Skip to main content
. 2020 Nov 10;11:583525. doi: 10.3389/fmicb.2020.583525

FIGURE 4.

FIGURE 4

Significantly different genera (A) and OTUs (B) based on the PCA plot between healthy individuals and NSCLC patients in response to osimertinib therapy.